Nine years of comparative effectiveness research education and training: Initiative supported by the PhRMA Foundation

Emily Beth Devine, Eleanor Perfetto, A. Simon Pickard, Glen T. Schumock, Jodi B. Segal, Eileen Cannon, Jean Paul Gagnon, Diana I. Brixner, Louis P. Garrison, Michael Murray

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The term comparative effectiveness research (CER) took center stage with passage of the American Recovery and Reinvestment Act (2009). The companion US$1.1 billion in funding prompted the launch of initiatives to train the scientific workforce capable of conducting and using CER. Passage of the Patient Protection and Affordable Care Act (2010) focused these initiatives on patients, coining the term 'patient-centered outcomes research' (PCOR). Educational and training initiatives were soon launched. This report describes the initiative of the Pharmaceutical Research and Manufacturers Association of America (PhRMA) Foundation. Through provision of grant funding to six academic Centers of Excellence, to spearheading and sponsoring three national conferences, the PhRMA Foundation has made significant contributions to creation of the scientific workforce that conducts and uses CER/PCOR.

Original languageEnglish (US)
Pages (from-to)167-175
Number of pages9
JournalJournal of Comparative Effectiveness Research
Volume7
Issue number2
DOIs
StatePublished - Feb 1 2018
Externally publishedYes

Fingerprint

Comparative Effectiveness Research
Patient Outcome Assessment
Education
American Recovery and Reinvestment Act
Patient Protection and Affordable Care Act
Organized Financing
Pharmaceutical Research

Keywords

  • centers of excellence
  • comparative effectiveness research
  • patient-centered outcomes research

ASJC Scopus subject areas

  • Health Policy

Cite this

Nine years of comparative effectiveness research education and training : Initiative supported by the PhRMA Foundation. / Devine, Emily Beth; Perfetto, Eleanor; Pickard, A. Simon; Schumock, Glen T.; Segal, Jodi B.; Cannon, Eileen; Gagnon, Jean Paul; Brixner, Diana I.; Garrison, Louis P.; Murray, Michael.

In: Journal of Comparative Effectiveness Research, Vol. 7, No. 2, 01.02.2018, p. 167-175.

Research output: Contribution to journalReview article

Devine, EB, Perfetto, E, Pickard, AS, Schumock, GT, Segal, JB, Cannon, E, Gagnon, JP, Brixner, DI, Garrison, LP & Murray, M 2018, 'Nine years of comparative effectiveness research education and training: Initiative supported by the PhRMA Foundation', Journal of Comparative Effectiveness Research, vol. 7, no. 2, pp. 167-175. https://doi.org/10.2217/cer-2017-0059
Devine, Emily Beth ; Perfetto, Eleanor ; Pickard, A. Simon ; Schumock, Glen T. ; Segal, Jodi B. ; Cannon, Eileen ; Gagnon, Jean Paul ; Brixner, Diana I. ; Garrison, Louis P. ; Murray, Michael. / Nine years of comparative effectiveness research education and training : Initiative supported by the PhRMA Foundation. In: Journal of Comparative Effectiveness Research. 2018 ; Vol. 7, No. 2. pp. 167-175.
@article{733bc7da14b6411a84240908d70105b5,
title = "Nine years of comparative effectiveness research education and training: Initiative supported by the PhRMA Foundation",
abstract = "The term comparative effectiveness research (CER) took center stage with passage of the American Recovery and Reinvestment Act (2009). The companion US$1.1 billion in funding prompted the launch of initiatives to train the scientific workforce capable of conducting and using CER. Passage of the Patient Protection and Affordable Care Act (2010) focused these initiatives on patients, coining the term 'patient-centered outcomes research' (PCOR). Educational and training initiatives were soon launched. This report describes the initiative of the Pharmaceutical Research and Manufacturers Association of America (PhRMA) Foundation. Through provision of grant funding to six academic Centers of Excellence, to spearheading and sponsoring three national conferences, the PhRMA Foundation has made significant contributions to creation of the scientific workforce that conducts and uses CER/PCOR.",
keywords = "centers of excellence, comparative effectiveness research, patient-centered outcomes research",
author = "Devine, {Emily Beth} and Eleanor Perfetto and Pickard, {A. Simon} and Schumock, {Glen T.} and Segal, {Jodi B.} and Eileen Cannon and Gagnon, {Jean Paul} and Brixner, {Diana I.} and Garrison, {Louis P.} and Michael Murray",
year = "2018",
month = "2",
day = "1",
doi = "10.2217/cer-2017-0059",
language = "English (US)",
volume = "7",
pages = "167--175",
journal = "Journal of Comparative Effectiveness Research",
issn = "2042-6305",
publisher = "Future Medicine Ltd.",
number = "2",

}

TY - JOUR

T1 - Nine years of comparative effectiveness research education and training

T2 - Initiative supported by the PhRMA Foundation

AU - Devine, Emily Beth

AU - Perfetto, Eleanor

AU - Pickard, A. Simon

AU - Schumock, Glen T.

AU - Segal, Jodi B.

AU - Cannon, Eileen

AU - Gagnon, Jean Paul

AU - Brixner, Diana I.

AU - Garrison, Louis P.

AU - Murray, Michael

PY - 2018/2/1

Y1 - 2018/2/1

N2 - The term comparative effectiveness research (CER) took center stage with passage of the American Recovery and Reinvestment Act (2009). The companion US$1.1 billion in funding prompted the launch of initiatives to train the scientific workforce capable of conducting and using CER. Passage of the Patient Protection and Affordable Care Act (2010) focused these initiatives on patients, coining the term 'patient-centered outcomes research' (PCOR). Educational and training initiatives were soon launched. This report describes the initiative of the Pharmaceutical Research and Manufacturers Association of America (PhRMA) Foundation. Through provision of grant funding to six academic Centers of Excellence, to spearheading and sponsoring three national conferences, the PhRMA Foundation has made significant contributions to creation of the scientific workforce that conducts and uses CER/PCOR.

AB - The term comparative effectiveness research (CER) took center stage with passage of the American Recovery and Reinvestment Act (2009). The companion US$1.1 billion in funding prompted the launch of initiatives to train the scientific workforce capable of conducting and using CER. Passage of the Patient Protection and Affordable Care Act (2010) focused these initiatives on patients, coining the term 'patient-centered outcomes research' (PCOR). Educational and training initiatives were soon launched. This report describes the initiative of the Pharmaceutical Research and Manufacturers Association of America (PhRMA) Foundation. Through provision of grant funding to six academic Centers of Excellence, to spearheading and sponsoring three national conferences, the PhRMA Foundation has made significant contributions to creation of the scientific workforce that conducts and uses CER/PCOR.

KW - centers of excellence

KW - comparative effectiveness research

KW - patient-centered outcomes research

UR - http://www.scopus.com/inward/record.url?scp=85042687755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042687755&partnerID=8YFLogxK

U2 - 10.2217/cer-2017-0059

DO - 10.2217/cer-2017-0059

M3 - Review article

C2 - 29464964

AN - SCOPUS:85042687755

VL - 7

SP - 167

EP - 175

JO - Journal of Comparative Effectiveness Research

JF - Journal of Comparative Effectiveness Research

SN - 2042-6305

IS - 2

ER -